FAITH LEBER: Open Payments
NPI 1609273994 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 27 payments from 14 companies in 2025. Trend: 2023 $1,549 · 2024 $1,200 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $285 |
| Novo Nordisk Inc | 4 | $180 |
| ABBVIE INC. | 4 | $162 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $116 |
| Lilly USA, LLC | 3 | $61 |
| Exact Sciences Corporation | 2 | $56 |
| SANOFI PASTEUR INC. | 1 | $37 |
| Dexcom, Inc. | 1 | $26 |
Products named: Wegovy, AIRSUPRA, VOQUEZNA, ZORYVE, UBRELVY, BREZTRI, Epclusa, MOUNJARO.
Industry payments across TX — which companies pay providers there.
